Veronica R Bravo: The Role of Off-pore Nucleoporins in Prostate Cancer Progression and Immune Evasion
Veronica R Bravo, Associate Professor at Mayo Clinic, shared a post on X by Elizabeth McKenna, Executive Editor of Cancer Discovery, adding:
“Very excited about our last paper in Cancer Discovery on the role of off-pore nucleoporins in prostate cancer progression and immune evasion.
An adventure into the nucleus with the best team.
Shout out to 1st authors Kirthika, Vijay, and Peiyao.”
Quoting Elizabeth McKenna‘s post:
“Now in Cancer Discovery:
Off-Pore Nucleoporin sPOM121 Propels β-Catenin-Driven Tumor Progression and Immune Escape in Prostate Cancer – by Perumalraja Kirthika, Vijayakumar Jawalagatti, Peiyao Li, Zhu Lab, Veronica R Bravo, Josep Domingo-Domenech et al..”
Title: Off-pore nucleoporin sPOM121 transcriptionally propels β-Catenin driven tumor progression and immune escape in prostate cancer
Journal: Cancer Discovery
Authors: Perumalraja Kirthika, Vijayakumar Jawalagatti, Peiyao Li, Michael Xu, Marc Carceles-Cordon, Adam Ertel, S. Aidan Quinn, Daniel P. Petrylak, Jacob J. Orme, Scott M. Dehm, Emmanuel S. Antonarakis, Elisabeth I. Heath, Mukesh K. Pandey, Carlos Cordon-Cardo, Haojie Huang, Haidong Dong, Shijia Zhu, Josep Domingo-Domenech, Veronica Rodriguez-Bravo
More posts featuring prostate cancer on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023